KZIA
Kazia Therapeutics Limited
NASDAQ · Healthcare · Biotechnology · AU
$12.31
+1.23%Margins
Gross margin
100.0%
EBITDA margin
-1792.6%
EBIT margin
-1866.7%
Net margin
-2008.8%
FCF margin
-655.2%
-109.2%
Return on equity
-71.3%
Return on assets
-101.2%
Return on invested capital
0.07x
Asset turnover
-$14.9M
Cash from operations
$3.57
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025